| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.043 | 0.7 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.057 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |